Among the 31 tumor types studied, FSCN1 was highly expressed in 16 tumor types ( P < 0.05), whereas FSCN1 expression was significantly lower in acute myeloid leukemia tissues (P < 0.05). Here, FSCN1 is linked to neoplasm.